Association of clinical and genetical features in FMF with focus on MEFV strip assay sensitivity in 452 children from western Anatolia, Turkey
- 5 November 2011
- journal article
- Published by Springer Science and Business Media LLC in Clinical Rheumatology
- Vol. 31 (3), 493-501
- https://doi.org/10.1007/s10067-011-1876-1
Abstract
The aim of this study was to determine the relationship between clinical findings and the most common mutated alleles of MEFV gene in a childhood population and to determine the sensitivity of the 12-mutation-strip assay test in familial Mediterranean fever (FMF). Records of 452 FMF children living in western Anatolia, Turkey, (12.3 ± 4.7 years mean) were retrospectively reviewed. Of the 408 patients who met the Tel-Hashomer criteria, 364 were classified into two main groups (two-mutant/one-mutant allele) either of which had three subgroups. The two-mutant allele frequency was 51% and one-mutant allele 38%; 1% had complex-mutant alleles and 10% no mutant-alleles. The mean severity score was 8.3 ± 2.5. Most common clinical features were fever (81.9%), abdominal pain (86.3%) and myalgia (58.8%), and the least common ones: diarrhea (1.7%), protracted febrile myalgia (1.2%) and acute orchitis (1.5%). We detected 33 different genotypes of the MEFV gene: the most common mutant allele was M694V followed by symptomatic allele mutation of E148Q. Although not significantly associated with clinical findings, P369S mutation was not rare (7.5%). Phenotype–genotype correlation revealed that patients with two-allele mutations had more severe clinical presentation and high constipation rate (22.5%); 32.6% of patients with M694V/M694V had splenomegaly. Acute orchitis and protracted febrile myalgia as rare clinical findings were more common in M694V homozygotes. Comparisons of clinical findings among patients with one-mutation allele were made for the first time, but no significant association was found. Positive predictive value of strip assay screening for 12 mutations was recorded as 89%. We suggest that whole sequence analysis for supportive diagnosis of FMF should be performed for selected patients only.This publication has 44 references indexed in Scilit:
- MEFV gene compound heterozygous mutations in familial Mediterranean fever phenotype: a retrospective clinical and molecular studyNephrology Dialysis Transplantation, 2009
- Analysis of Familial Mediterranean Fever Gene Mutations in 202 Patients with Familial Mediterranean FeverGenetic Testing, 2008
- E148Q is a disease-causing MEFV mutation: a phenotypic evaluation in patients with familial Mediterranean feverAnnals Of The Rheumatic Diseases, 2005
- Reverse-Hybridization vs. DNA Sequencing in the Molecular Diagnosis of Familial Mediterranean FeverGenetic Testing, 2004
- Colchicine treatment in children with familial Mediterranean feverClinical Rheumatology, 2003
- Mutation frequency of Familial Mediterranean Fever and evidence for a high carrier rate in the Turkish populationEuropean Journal of Human Genetics, 2001
- The spectrum of Familial Mediterranean Fever (FMF) mutationsEuropean Journal of Human Genetics, 2001
- MEFV mutations in Turkish patients suffering from familial Mediterranean feverHuman Mutation, 1999
- A candidate gene for familial Mediterranean feverNature Genetics, 1997
- Long-term colchicine prophylaxis in children with familial Mediterranean fever (recurrent hereditary polyserositis)The Journal of Pediatrics, 1990